▶ 調査レポート

世界のPARP（ポリADPリボースポリメラーゼ）阻害剤市場：市場規模・現状・予測
• 英文タイトル：Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。世界のPARP（ポリADPリボースポリメラーゼ）阻害剤市場：市場規模・現状・予測 / Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size, Status and Forecast 2019-2025 / QYR9N7768資料のイメージです。• レポートコード：QYR9N7768
• 出版社/出版日：QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、93ページ
• 納品方法：Eメール（受注後２～3営業日）
• 産業分類：医療・製薬・バイオ
• 販売価格（消費税別）
  Single User￥585,000 (USD3,900)▷ お問い合わせ
  Enterprise License￥1,170,000 (USD7,800)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
当資料は、PARP（ポリADPリボースポリメラーゼ）阻害剤のグローバル市場について調査・分析したレポートで、種類別（開始フェーズI、開始フェーズII、開始フェーズIII）、用途別（病院、ドラッグストア、オンライン）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。

・PARP（ポリADPリボースポリメラーゼ）阻害剤の世界市場規模
・主要企業別市場シェア
・PARP（ポリADPリボースポリメラーゼ）阻害剤の世界市場規模：種類別（開始フェーズI、開始フェーズII、開始フェーズIII）
・PARP（ポリADPリボースポリメラーゼ）阻害剤の世界市場規模：用途別（病院、ドラッグストア、オンライン）
・PARP（ポリADPリボースポリメラーゼ）阻害剤のアメリカ市場規模（種類別、用途別）
・PARP（ポリADPリボースポリメラーゼ）阻害剤のヨーロッパ市場規模（種類別、用途別）
・PARP（ポリADPリボースポリメラーゼ）阻害剤の中国市場規模（種類別、用途別）
・PARP（ポリADPリボースポリメラーゼ）阻害剤の日本市場規模（種類別、用途別）
・PARP（ポリADPリボースポリメラーゼ）阻害剤の東南アジア市場規模（種類別、用途別）
・PARP（ポリADPリボースポリメラーゼ）阻害剤のインド市場規模（種類別、用途別）
・PARP（ポリADPリボースポリメラーゼ）阻害剤の中南米市場規模（種類別、用途別）
・主要企業別分析（企業概要、製品動向、販売量など）
・PARP（ポリADPリボースポリメラーゼ）阻害剤の世界市場予測（2019年-2025年）
・PARP（ポリADPリボースポリメラーゼ）阻害剤の地域別市場予測（2019年-2025年）
...

PARP means poly (adenosine diphosphate [ADP] -ribose) polymerase. It is a family of 17 enzymes that combine several (poly) units of ADP-ribose in a chain (the PAR chain) and transfers them to the target proteins. This helps to restore DNA when it is damaged. DNA can be damaged by many factors, including exposure to UV rays, radiation, some anti-cancer drugs or other substances in the environment. PARP inhibitors block an enzyme critical to the repair of single stranded breaks in DNA. Inhibition of this DNA repair enzyme can lead to cell death, particularly in cancer cells that carry deficiency in other DNA repair pathways.The U.S. is the major market of PARP inhibitor supported by PARPi for ovarian cancer in the market. The U.S. region is likely to experience further growth of PARP inhibitor market with upcoming PARP inhibitors and growing cases of cancer.
In 2018, the global PARP (Poly ADP-Ribose Polymerase) Inhibitor market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global PARP (Poly ADP-Ribose Polymerase) Inhibitor status, future forecast, growth opportunity, key market and key players. The study objectives are to present the PARP (Poly ADP-Ribose Polymerase) Inhibitor development in United States, Europe and China.

The key players covered in this study
Tesaro
Clovis Oncology
AstraZeneca
Abbvie
…

Market segment by Type, the product can be split into
Started Phase I
Started Phase II
Started Phase III

Market segment by Application, split into
Hospitals
Drug Stores
Online

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global PARP (Poly ADP-Ribose Polymerase) Inhibitor status, future forecast, growth opportunity, key market and key players.
To present the PARP (Poly ADP-Ribose Polymerase) Inhibitor development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of PARP (Poly ADP-Ribose Polymerase) Inhibitor are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size Growth Rate by Type (2014-2025)
1.4.2 Started Phase I
1.4.3 Started Phase II
1.4.4 Started Phase III
1.5 Market by Application
1.5.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Share by Application (2014-2025)
1.5.2 Hospitals
1.5.3 Drug Stores
1.5.4 Online
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size
2.2 PARP (Poly ADP-Ribose Polymerase) Inhibitor Growth Trends by Regions
2.2.1 PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Regions (2014-2025)
2.2.2 PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Manufacturers
3.1.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue by Manufacturers (2014-2019)
3.1.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Concentration Ratio (CR5 and HHI)
3.2 PARP (Poly ADP-Ribose Polymerase) Inhibitor Key Players Head office and Area Served
3.3 Key Players PARP (Poly ADP-Ribose Polymerase) Inhibitor Product/Solution/Service
3.4 Date of Enter into PARP (Poly ADP-Ribose Polymerase) Inhibitor Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Type (2014-2019)
4.2 Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Application (2014-2019)

5 United States
5.1 United States PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size (2014-2019)
5.2 PARP (Poly ADP-Ribose Polymerase) Inhibitor Key Players in United States
5.3 United States PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Type
5.4 United States PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Application

6 Europe
6.1 Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size (2014-2019)
6.2 PARP (Poly ADP-Ribose Polymerase) Inhibitor Key Players in Europe
6.3 Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Type
6.4 Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Application

7 China
7.1 China PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size (2014-2019)
7.2 PARP (Poly ADP-Ribose Polymerase) Inhibitor Key Players in China
7.3 China PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Type
7.4 China PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Application

8 Japan
8.1 Japan PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size (2014-2019)
8.2 PARP (Poly ADP-Ribose Polymerase) Inhibitor Key Players in Japan
8.3 Japan PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Type
8.4 Japan PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Application

9 Southeast Asia
9.1 Southeast Asia PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size (2014-2019)
9.2 PARP (Poly ADP-Ribose Polymerase) Inhibitor Key Players in Southeast Asia
9.3 Southeast Asia PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Type
9.4 Southeast Asia PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Application

10 India
10.1 India PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size (2014-2019)
10.2 PARP (Poly ADP-Ribose Polymerase) Inhibitor Key Players in India
10.3 India PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Type
10.4 India PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Application

11 Central & South America
11.1 Central & South America PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size (2014-2019)
11.2 PARP (Poly ADP-Ribose Polymerase) Inhibitor Key Players in Central & South America
11.3 Central & South America PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Type
11.4 Central & South America PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Application

12 International Players Profiles
12.1 Tesaro
12.1.1 Tesaro Company Details
12.1.2 Company Description and Business Overview
12.1.3 PARP (Poly ADP-Ribose Polymerase) Inhibitor Introduction
12.1.4 Tesaro Revenue in PARP (Poly ADP-Ribose Polymerase) Inhibitor Business (2014-2019)
12.1.5 Tesaro Recent Development
12.2 Clovis Oncology
12.2.1 Clovis Oncology Company Details
12.2.2 Company Description and Business Overview
12.2.3 PARP (Poly ADP-Ribose Polymerase) Inhibitor Introduction
12.2.4 Clovis Oncology Revenue in PARP (Poly ADP-Ribose Polymerase) Inhibitor Business (2014-2019)
12.2.5 Clovis Oncology Recent Development
12.3 AstraZeneca
12.3.1 AstraZeneca Company Details
12.3.2 Company Description and Business Overview
12.3.3 PARP (Poly ADP-Ribose Polymerase) Inhibitor Introduction
12.3.4 AstraZeneca Revenue in PARP (Poly ADP-Ribose Polymerase) Inhibitor Business (2014-2019)
12.3.5 AstraZeneca Recent Development
12.4 Abbvie
12.4.1 Abbvie Company Details
12.4.2 Company Description and Business Overview
12.4.3 PARP (Poly ADP-Ribose Polymerase) Inhibitor Introduction
12.4.4 Abbvie Revenue in PARP (Poly ADP-Ribose Polymerase) Inhibitor Business (2014-2019)
12.4.5 Abbvie Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table PARP (Poly ADP-Ribose Polymerase) Inhibitor Key Market Segments
Table Key Players PARP (Poly ADP-Ribose Polymerase) Inhibitor Covered
Table Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size Market Share by Type 2014-2025
Figure Started Phase I Figures
Table Key Players of Started Phase I
Figure Started Phase II Figures
Table Key Players of Started Phase II
Figure Started Phase III Figures
Table Key Players of Started Phase III
Table Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals Case Studies
Figure Drug Stores Case Studies
Figure Online Case Studies
Figure PARP (Poly ADP-Ribose Polymerase) Inhibitor Report Years Considered
Table Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size 2014-2025 (Million US$)
Figure Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size and Growth Rate 2014-2025 (Million US$)
Table Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Regions 2014-2025 (Million US$)
Table Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Regions 2014-2019 (Million US$)
Table Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Share by Regions 2014-2019
Figure Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Share by Regions 2014-2019
Figure Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Share by Regions 2019
Table Market Top Trends
Table Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue by Manufacturers (2014-2019) (Million US$)
Table Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Share by Manufacturers (2014-2019)
Figure Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Share by Manufacturers in 2018
Table Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players PARP (Poly ADP-Ribose Polymerase) Inhibitor Product/Solution/Service
Table Date of Enter into PARP (Poly ADP-Ribose Polymerase) Inhibitor Market
Table Mergers & Acquisitions, Expansion Plans
Table Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Type (2014-2019) (Million US$)
Table Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size Share by Type (2014-2019)
Figure Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size Market Share by Type (2014-2019)
Table Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Application (2014-2019) (Million US$)
Table Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size Share by Application (2014-2019)
Figure Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size Market Share by Application (2014-2019)
Figure Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue Market Share by Application in 2018
Figure United States PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size 2014-2019 (Million US$)
Table United States Key Players PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue (2018-2019) (Million US$)
Table United States Key Players PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Share (2018-2019)
Table United States PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Type (2014-2019) (Million US$)
Table United States PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Share by Type (2014-2019)
Table United States PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Application (2014-2019) (Million US$)
Table United States PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Share by Application (2014-2019)
Figure Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size 2014-2019 (Million US$)
Table Europe Key Players PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue (2018-2019) (Million US$)
Table Europe Key Players PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Share (2018-2019)
Table Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Type (2014-2019) (Million US$)
Table Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Share by Type (2014-2019)
Table Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Application (2014-2019) (Million US$)
Table Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Share by Application (2014-2019)
Figure China PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size 2014-2019 (Million US$)
Table China Key Players PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue (2018-2019) (Million US$)
Table China Key Players PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Share (2018-2019)
Table China PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Type (2014-20189) (Million US$)
Table China PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Share by Type (2014-2019)
Table China PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Application (2014-2019) (Million US$)
Table China PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Share by Application (2014-2019)
Figure Japan PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size 2014-2019 (Million US$)
Table Japan Key Players PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue (2018-2019) (Million US$)
Table Japan Key Players PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Share (2018-2019)
Table Japan PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Type (2014-2019) (Million US$)
Table Japan PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Share by Type (2014-2019)
Table Japan PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Application (2014-2019) (Million US$)
Table Japan PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Share by Application (2014-2019)
Figure Southeast Asia PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Share (2018-2019)
Table Southeast Asia PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Share by Type (2014-2019)
Table Southeast Asia PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Share by Application (2014-2019)
Figure India PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size 2014-2019 (Million US$)
Table India Key Players PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue (2018-2019) (Million US$)
Table India Key Players PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Share (2018-2019)
Table India PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Type (2014-2019) (Million US$)
Table India PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Share by Type (2014-2019)
Table India PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Application (2014-2019) (Million US$)
Table India PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Share by Application (2014-2019)
Figure Central & South America PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size 2014-2019 (Million US$)
Table Central & South America Key Players PARP (Poly ADP-Ribose Polymerase) Inhibitor Revenue (2018-2019) (Million US$)
Table Central & South America Key Players PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Share (2018-2019)
Table Central & South America PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Type (2014-2019) (Million US$)
Table Central & South America PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Share by Type (2014-2019)
Table Central & South America PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Application (2014-2019) (Million US$)
Table Central & South America PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Share by Application (2014-2019)
Table Tesaro Company Details
Table Tesaro Revenue in PARP (Poly ADP-Ribose Polymerase) Inhibitor Business (2014-2019) (Million US$)
Figure Tesaro Revenue Growth Rate in PARP (Poly ADP-Ribose Polymerase) Inhibitor Business (2014-2019)
Table Tesaro Recent Development
Table Clovis Oncology Company Details
Table Clovis Oncology Revenue in PARP (Poly ADP-Ribose Polymerase) Inhibitor Business (2014-2019)(Million US$)
Figure Clovis Oncology Revenue Growth Rate in PARP (Poly ADP-Ribose Polymerase) Inhibitor Business (2014-2019)
Table Clovis Oncology Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in PARP (Poly ADP-Ribose Polymerase) Inhibitor Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in PARP (Poly ADP-Ribose Polymerase) Inhibitor Business (2014-2019)
Table AstraZeneca Recent Development
Table Abbvie Company Details
Table Abbvie Revenue in PARP (Poly ADP-Ribose Polymerase) Inhibitor Business (2014-2019)(Million US$)
Figure Abbvie Revenue Growth Rate in PARP (Poly ADP-Ribose Polymerase) Inhibitor Business (2014-2019)
Table Abbvie Recent Development
Table Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Regions (Million US$) 2019-2025
Figure Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size Share by Regions (2019-2025)
Figure Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size Share by Regions in 2025
Figure United States PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size Forecast (2019-2025)(Million USD)
Figure Europe PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size Forecast (2019-2025)(Million USD)
Figure China PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size Forecast (2019-2025)(Million USD)
Figure Japan PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size Forecast (2019-2025)(Million USD)
Figure India PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size Forecast (2019-2025)(Million USD)
Table Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Product (2019-2025) (Million US$)
Figure Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Product (2019-2025)
Figure Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Product in 2025
Table Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Application (2019-2025) (Million US$)
Figure Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Application (2019-2025)
Figure Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

以下、関連資料のご紹介
  • 世界のポリメラーゼ2市場2019
    Global Poly Polymerase 2 Sales Market Report 2019
    QYR9N3537 2019年6月13日 103Pages
    本調査レポートでは、ポリメラーゼ2の世界市場について調査・分析し、ポリメラーゼ2のメーカー別販売量、市場シェア分析、種類別販売分析（BGB-290、AZ-0108、CK-102、NOV-1401、その他）、用途別販売分析（腹膜がん、B細胞性慢性リンパ性白血病、喉頭がん、その他）、地域別販売分析（米国...
  • 世界のポリメラーゼ連鎖反応（PCR）試験市場：市場規模・現状・予測
    Global Polymerase Chain Reaction (PCR) Test Market Size, Status and Forecast 2019-2025
    QYR9N7859 2019年6月14日 103Pages
    当資料は、ポリメラーゼ連鎖反応（PCR）試験のグローバル市場について調査・分析したレポートで、種類別（器械、試薬および消耗品、ソフトウェアとサービス）、用途別（病院、診療所、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含...
  • 世界のリアルタイムポリメラーゼ連鎖反応システム市場：市場規模・現状・予測
    Global Real Time Polymerase Chain Reaction Systems Market Size, Status and Forecast 2019-2025
    QYR9N7939 2019年6月14日 97Pages
    当資料は、リアルタイムポリメラーゼ連鎖反応システムのグローバル市場について調査・分析したレポートで、種類別（非特異的検出、特定の検出）、用途別（遺伝子発現解析、ジェノタイピング、GMOの検出、その他）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関...
  • 世界のSDSポリアクリルアミドゲル電気泳動市場：市場規模・現状・予測
    Global SDS Poly Acrylamide Gel Electrophoresis Market Size, Status and Forecast 2019-2025
    QYR9N8003 2019年6月14日 98Pages
    当資料は、SDSポリアクリルアミドゲル電気泳動のグローバル市場について調査・分析したレポートで、種類別（ゲル、試薬、器械）、用途別（臨床研究、バイオテクノロジーと製薬産業、政府機関、学術機関）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情...
  • 世界のプラスミノーゲンアクチベーター阻害剤1市場2019
    Global Plasminogen Activator Inhibitor 1 Sales Market Report 2019
    QYR9N3461 2019年6月13日 105Pages
    本調査レポートでは、プラスミノーゲンアクチベーター阻害剤1の世界市場について調査・分析し、プラスミノーゲンアクチベーター阻害剤1のメーカー別販売量、市場シェア分析、種類別販売分析（SK-216、THR-18、デフィブロチドナトリウム、CT-140、その他）、用途別販売分析（血栓症、急性虚血性脳卒中、...
  • 世界の血漿プロテアーゼC1阻害剤治療市場2019
    Global Plasma Protease C1-inhibitor Treatment Sales Market Report 2019
    QYR9N3459 2019年6月13日 101Pages
    本調査レポートでは、血漿プロテアーゼC1阻害剤治療の世界市場について調査・分析し、血漿プロテアーゼC1阻害剤治療のメーカー別販売量、市場シェア分析、種類別販売分析（C1阻害剤、カリクレインインヒビター（Kalbitor）、選択的ブラジキニンB2受容体拮抗薬（Firazyr））、用途別販売分析（病院薬...
  • 世界の核因子κBキナーゼサブユニットベータの阻害剤市場2019
    Global Inhibitor of Nuclear Factor Kappa B Kinase Subunit Beta Sales Market Report 2019
    QYR9N1955 2019年6月10日 102Pages
    本調査レポートでは、核因子κBキナーゼサブユニットベータの阻害剤の世界市場について調査・分析し、核因子κBキナーゼサブユニットベータの阻害剤のメーカー別販売量、市場シェア分析、種類別販売分析（TLX-1423、IMD-0560、EC-70124、その他）、用途別販売分析（大腸がん、乳がん、膵がん、前...
  • 世界の油田腐食とスケール防止剤市場2019
    Global Oilfield Corrosion and Scale Inhibitor Sales Market Report 2019
    QYR9N3029 2019年6月13日 101Pages
    本調査レポートでは、油田腐食とスケール防止剤の世界市場について調査・分析し、油田腐食とスケール防止剤のメーカー別販売量、市場シェア分析、種類別販売分析（無機リン酸塩、有機リン化合物、ポリマースケール防止剤、その他）、用途別販売分析（水処理、石油ガス、その他）、地域別販売分析（米国、ヨーロッパ、中国、...
  • 世界のリアルタイムポリメラーゼ連鎖反応（PCR）装置市場2019
    Global Real-time Polymerase Chain Reaction (PCR) Machines Sales Market Report 2019
    QYR9N3917 2019年6月13日 102Pages
    本調査レポートでは、リアルタイムポリメラーゼ連鎖反応（PCR）装置の世界市場について調査・分析し、リアルタイムポリメラーゼ連鎖反応（PCR）装置のメーカー別販売量、市場シェア分析、種類別販売分析（LED、ハロゲンランプ、その他）、用途別販売分析（大学、病院、その他）、地域別販売分析（米国、ヨーロッパ...
  • 世界のポリクロロトリフルオロエチレン市場2019
    Global Poly-Chlorotrifluoroethylene Sales Market Report 2019
    QYR9N3547 2019年6月13日 101Pages
    本調査レポートでは、ポリクロロトリフルオロエチレンの世界市場について調査・分析し、ポリクロロトリフルオロエチレンのメーカー別販売量、市場シェア分析、種類別販売分析（懸濁液、乳化重合）、用途別販売分析（耐食部品、ケーブル、コーティング）、地域別販売分析（米国、ヨーロッパ、中国、日本、東南アジア、インド...
  • 世界のポリメラーゼ2市場2019世界のポリメラーゼ2市場2019 The global Poly Polymerase 2 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Poly Polymerase 2 market status and forecast, categorizes the global Poly Polymerase 2 market size (value & volum…
  • 世界のポリメラーゼ連鎖反応（PCR）試験市場：市場規模・現状・予測世界のポリメラーゼ連鎖反応（PCR）試験市場：市場規模・現状・予測 Polymerase chain reaction (PCR) is a technology that has opened up new vistas for advances in life sciences research and molecular diagnostics due to its attributes, such as detection and quantification of DNA and RNA genetic materials.In 2018, the global Polymerase Chain Reaction (PCR) Test market …
  • 世界のリアルタイムポリメラーゼ連鎖反応システム市場：市場規模・現状・予測世界のリアルタイムポリメラーゼ連鎖反応システム市場：市場規模・現状・予測 A real-time polymerase chain reaction (Real-Time PCR), also known as quantitative polymerase chain reaction (qPCR), is a laboratory technique of molecular biology based on the polymerase chain reaction (PCR).Majorly used techniques in Real Time Polymerase Chain Reaction to detect products are sequen…
  • 世界の単相リクローザ市場2019世界の単相リクローザ市場2019 The global Single Phase Recloser market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Single Phase Recloser market status and forecast, categorizes the global Single Phase Recloser market size (v…
  • 世界の単相インデュークチンモーター市場2019世界の単相インデュークチンモーター市場2019 The global Single Phase Inductin Motor market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Single Phase Inductin Motor market status and forecast, categorizes the global Single Phase Inductin Mo…